Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 5/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 5/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3672948 | 0.80 | SLC6A4 (0.43) | SLC6A4SLC6A3SLC6A2 | |
| SCHEMBL6062808 | 0.77 | SLC6A4 (0.44) | SLC6A4SLC6A3SLC6A2 | |
| SCHEMBL1341336 | 0.77 | SLC6A4 (0.44) | SLC6A4SLC6A3SLC6A2 | |
| SCHEMBL28834986 | 0.74 | SLC6A4 (0.41) | SLC6A4SLC6A3SLC6A2 | |
| Hydrochloric Acid SCHEMBL23909488 | 0.70 | SLC6A4 (0.39) | SLC6A4SLC6A3SLC6A2 | |
| Hydrochloric Acid SCHEMBL23909486 | 0.70 | SLC6A4 (0.39) | SLC6A4SLC6A3SLC6A2 | |
| SCHEMBL185384 | 0.69 | SLC6A3 (0.39) | SLC6A4SLC6A3SLC6A2 | |
| SCHEMBL5667980 | 0.69 | SLC6A4 (0.39) | SLC6A4SLC6A3SLC6A2 | |
| SCHEMBL3035967 | 0.69 | SLC6A4 (0.42) | SLC6A4SLC6A3SLC6A2 | |
| SCHEMBL8114195 | 0.68 | TSHR (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12180136-B2 | Organic amine collection method | ASAHI KASEL KABUSHIKI KAISHA (JP) | 2024-12-31 | — | — | US | claimed |
| US-20230139979-A1 | ORGANIC AMINE COLLECTION METHOD | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2023-05-04 | — | — | US | claimed |
| EP-3872062-B1 | ORGANIC AMINE COLLECTION METHOD | ASAHI CHEMICAL IND (JP) | 2022-09-07 | — | — | EP | claimed |
| US-12180136-B2 | Organic amine collection method | ASAHI KASEL KABUSHIKI KAISHA (JP) | 2024-12-31 | — | — | US | disclosed |
| US-20230139979-A1 | ORGANIC AMINE COLLECTION METHOD | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2023-05-04 | — | — | US | disclosed |
| US-11578030-B2 | Organic amine collection method | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2023-02-14 | — | — | US | disclosed |
| EP-3733644-B1 | ORGANIC AMINE COLLECTION METHOD | ASAHI CHEMICAL IND (JP) | 2022-09-07 | — | — | EP | disclosed |
| EP-3872062-B1 | ORGANIC AMINE COLLECTION METHOD | ASAHI CHEMICAL IND (JP) | 2022-09-07 | — | — | EP | disclosed |
| US-20210155573-A1 | ORGANIC AMINE COLLECTION METHOD | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2021-05-27 | — | — | US | disclosed |
| EP-3733644-A1 | ORGANIC AMINE COLLECTION METHOD | Asahi Kasei Kabushiki Kaisha (JP) | 2020-11-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230139979-A1 | ORGANIC AMINE COLLECTION METHOD | H1-0, F12, C1S | SLC6A4 1424/4885SLC6A3 1496/4885SLC6A2 1235/4885 |
| US-11578030-B2 | Organic amine collection method | H1-0, C1S, NGLY1 | SLC6A4 1628/4885SLC6A3 1616/4885SLC6A2 1038/4885 |
| US-12180136-B2 | Organic amine collection method | H1-0, F12, C1S | SLC6A4 1424/4885SLC6A3 1496/4885SLC6A2 1235/4885 |
| US-20210155573-A1 | ORGANIC AMINE COLLECTION METHOD | H1-0, C1S, NGLY1 | SLC6A4 1628/4885SLC6A3 1616/4885SLC6A2 1038/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.